USPTO Examiner HUSSAIN NIDAH MAHREEN - Art Unit 3783

Recent Applications

Detailed information about the 100 most recent patent applications.

Application NumberTitleFiling DateDisposal DateDispositionTime (months)Office ActionsRestrictionsInterviewAppeal
17134239AUTOMATIC INJECTION DEVICE FOR FLUIDDecember 2020February 2024Allow3810NoNo
17131478INTEGRATED VASCULAR ACCESS DEVICE AND ANCHOR PADDecember 2020September 2023Allow3310YesNo
17120670Drug Delivery DeviceDecember 2020November 2023Allow3520YesNo
17112017MEDICAL TUBE CLEARANCE DEVICEDecember 2020September 2023Allow3410NoNo
17108693FLUID INJECTION DEVICEDecember 2020June 2024Allow4320YesNo
17095450INJECTOR SYSTEMS AND SYRINGE ADAPTERS FOR USE THEREWITHNovember 2020November 2022Allow2410NoNo
17094176DRUG DELIVERY SYSTEM WITH FLEXIBLE PISTON ASSEMBLYNovember 2020April 2024Allow4121YesNo
17085761MEDICAMENT DELIVERY DEVICE AND METHODS FOR DELIVERING DRUGS TO INFANTS AND CHILDRENOctober 2020July 2023Allow3310NoNo
17082578ENHANCED NEEDLEOctober 2020September 2024Abandon4621NoNo
17083129MEDICAMENT DEVICE FOR USE WITH A CONVENTIONAL SYRINGEOctober 2020March 2024Abandon4101NoNo
17039570DRUG CARTRIDGE WITH DRIVE SYSTEMSeptember 2020February 2023Allow2800YesNo
17036556DRUG DELIVERY DEVICESeptember 2020January 2024Allow4020YesNo
17041968SYSTEMS AND METHODS FOR AUTOMATICALLY REMOVING A NEEDLE CAP OF AN AUTOINJECTORSeptember 2020December 2024Allow5020YesNo
17042070STOPPER WITH LOW FORCE FOR USE IN AN INJECTORSeptember 2020May 2022Allow2020NoNo
17031516BREAST SHIELD WITH A FLEXIBLE EDGESeptember 2020February 2023Allow2910YesNo
17017468PATCH DELIVERY DEVICE WITH SKIN CONTACT SENSORSeptember 2020March 2024Allow4220YesNo
17003108LIQUID MEDICATION INJECTION DEVICEAugust 2020May 2023Allow3210YesNo
16999446MEDICATION DELIVERY SYSTEMS AND METHODSAugust 2020November 2023Allow3930NoNo
16998181STEERABLE CATHETER HANDLE DESIGNAugust 2020January 2024Allow4120NoNo
16996533DOSAGE DETERMINATION USING ELECTRICAL CONDUCTIVITY IN AN INJECTION DEVICEAugust 2020February 2024Abandon4210NoNo
16987019SUPPLEMENTAL DEVICE FOR ATTACHMENT TO A PEN INJECTOR AND DETERMINATION OF A SET DOSE AMOUNT USING OPTICAL INCREMENTAL ENCODERAugust 2020December 2023Allow4020NoNo
16956615NEEDLE DISC ROLLER APPARATUS WITH PUMPJune 2020August 2021Allow1330YesNo
16956370A Device for Attachment to an Injection DeviceJune 2020October 2023Allow4020YesNo
16906556INJECTION DEVICE WITH A CAP FOR REMOVING A NEEDLE PROTECTION CAP FROM A PRODUCT CONTAINER, AND METHOD FOR PROVIDING SUCH AN INJECTION DEVICEJune 2020October 2022Allow2700YesNo
16903190SYSTEM FOR HUMIDIFICATION OF MEDICAL GASESJune 2020September 2024Allow5140NoNo
16896961Catheter HandleJune 2020September 2022Allow2800YesNo
16769068Spring straining mechanism for torsion spring based deviceJune 2020February 2023Allow3330NoNo
16888500SYSTEMS AND METHODS FOR ASPIRATION AND MONITORINGMay 2020July 2023Allow3820YesNo
16768152Injector DeviceMay 2020June 2023Allow3720YesNo
16761552AUTO-INJECTORMay 2020November 2023Allow4230YesNo
16759488Drug Delivery DeviceApril 2020January 2023Allow3210NoNo
16758676PLUNGER AND DRUG DELIVERY DEVICEApril 2020October 2022Allow3020NoNo
16758781DRUG DELIVERY DEVICEApril 2020October 2022Allow3010NoNo
16756158An Injection Device with a Vibration GeneratorApril 2020March 2023Allow3520YesNo
16847281TRANS-JUGULAR CAROTID ARTERY ACCESS METHODSApril 2020October 2022Allow3011YesNo
16844858Autoinjectors Having Advanced Release and Sound FeaturesApril 2020July 2023Allow3921YesNo
16753836Injector DeviceApril 2020March 2022Allow2410NoNo
16826242ADAPTABLE MULTIPROCEDURAL SHARPS SAFETY DEVICEMarch 2020June 2024Allow5140NoNo
16649334DRIVE UNIT FOR A MEDICAMENT DELIVERY DEVICEMarch 2020February 2023Allow3530YesNo
16817975AUTO INJECTOR DEVICEMarch 2020July 2023Allow4030YesNo
16646086BALLOON CATHETER WITH WORKING TUBEMarch 2020July 2023Abandon4130NoNo
16784735PRESSURE-SENSING BLEED-BACK CONTROL VALVE WITH IMPROVED SEALINGFebruary 2020March 2022Allow2610YesNo
16781203HEMOSTASIS VALVE ORIENTATION RELATIVE TO THE FLUID SPACE IN A INTRODUCER SHEATHFebruary 2020May 2023Allow3931YesNo
16632523Assisted Injection Device for Injecting a Composition Contained in a Medical Container with Reduced EffortsJanuary 2020January 2023Allow3611YesNo
16740988MEDICAL TUBE CLEARANCE DEVICEJanuary 2020August 2020Allow710NoNo
16630377TRANSPORT ASSEMBLY FOR A MEDICAMENT DELIVERY DEVICE AND A MEDICAMENT DELIVERY DEVICE COMPRISING THE SAMEJanuary 2020June 2022Allow2910YesNo
16713837Injector With Adjustable DosingDecember 2019June 2022Allow3010YesNo
16694346COLD SLURRY SYRINGENovember 2019November 2021Allow2410NoNo
16612246Transport Lock Assembly, and a Medicament Delivery Device Comprising the Transport Lock AssemblyNovember 2019October 2021Allow2310NoNo
16605304E-CONNECTED AUTO-INJECTORSOctober 2019April 2022Abandon3001NoNo
16600193VASCULAR TREATMENT APPARATUS WITH REMOTE OPERATING MODULEOctober 2019August 2023Abandon4631NoNo
16600208VASCULAR TREATMENT APPARATUS WITH AUTO INJECTION DEVICE AND RELATED METHODSOctober 2019March 2022Abandon2910NoNo
16586469INJECTION DEVICE END OF DOSE INDICATORSeptember 2019February 2022Allow2910NoNo
16585716INJECTION DEVICE FILL VOLUME MANAGEMENTSeptember 2019December 2022Allow3911YesNo
16585322INJECTION DEVICE FILL VOLUME MANAGEMENTSeptember 2019March 2022Allow2910YesNo
16578498MEDICATION DELIVERY SYSTEMS AND METHODSSeptember 2019May 2020Allow800NoNo
16578068PORTABLE MEDICAL DEVICE AND CONTROL METHOD OF PORTABLE MEDICAL DEVICESeptember 2019February 2024Abandon5310NoNo
16495868AUTO-INJECTORSeptember 2019June 2022Allow3210YesNo
16576670INJECTION SPRING FOR AGED PREFILLED SYRINGE AND AUTO INJECTORSeptember 2019November 2022Allow3830YesNo
16494338INJECTION DEVICE WITH VELOCITY REGULATORSeptember 2019February 2022Allow2910YesNo
16572542Wearable Micro-LED Healing BandageSeptember 2019June 2022Abandon3320NoNo
16494025NEEDLE COVERSeptember 2019January 2022Allow2820YesNo
16493658DOSE CAPTURING ASSEMBLY WITH SECONDARY IMAGE ANALYSIS FEATURESeptember 2019January 2023Allow4030YesNo
16489577ENCAPSULATION DEVICE, DRUG DELIVERY DEVICE AND EMERGENCY PACKAugust 2019November 2022Allow3940NoNo
16487935Injection Device Having a Capability of Controlling Injection DoseAugust 2019June 2022Abandon3410NoNo
16478793INJECTOR SYSTEMS AND SYRINGE ADAPTERS FOR USE THEREWITHJuly 2019July 2020Allow1210NoNo
16457605MEDICAMENT DEVICE FOR USE WITH A CONVENTIONAL SYRINGEJune 2019December 2021Abandon2911NoNo
16471300SYRINGE PLUNGER WITH DYNAMIC SEALJune 2019March 2022Allow3320NoNo
16440955SYSTEMS AND METHODS FOR ASPIRATION AND MONITORINGJune 2019May 2020Allow1120YesNo
16431992AMBULATORY INFUSION DEVICEJune 2019December 2022Allow4240YesNo
16463223MANUAL INJECTOR FOR SKINMay 2019October 2021Allow2910NoNo
16463267CATHETER AND METHOD FOR MANUFACTURING CATHETERMay 2019March 2024Abandon5851NoNo
16348847MEDICAMENT DELIVERY DEVICE ADAPTED FOR LONG TERM STORAGEMay 2019December 2021Allow3120NoNo
16347712NOVEL SPRING-LOADED SUBCUTANEOUS AND INTERMUSCULAR INJECTOR DEVICEMay 2019September 2021Abandon2910NoNo
16378064GUIDEWIRE SECUREMENT DEVICEApril 2019March 2023Abandon4740YesNo
16339004BENDABLE TUBE WITH IMPROVED ELASTIC HINGEApril 2019January 2022Allow3420YesNo
16338214INJECTION DEVICEMarch 2019February 2022Allow3520YesNo
16336917AUTO-INJECTORMarch 2019August 2021Abandon2901NoNo
16331115CONTAINER FOR HOLDING A LIQUIDMarch 2019August 2021Allow2920NoNo
16291501THERAPEUTIC DEVICE FOR FEMALE GENITAL PREDICTIVE PERMEATIONMarch 2019September 2021Allow3020NoNo
16325325MICRONEEDLE SHEETFebruary 2019February 2021Allow2410YesNo
16241884MEDICAMENT DEVICE FOR USE WITH A CONVENTIONAL SYRINGEJanuary 2019July 2021Abandon3001NoNo
16308425ACOUSTIC FLOW SENSOR FOR CONTINUOUS MEDICATION FLOW MEASUREMENTS AND FEEDBACK CONTROL OF INFUSIONDecember 2018January 2022Allow3720NoYes
16305275DEVICES, SYSTEMS, AND METHODS FOR DELIVERY OF SOLID FORMULATIONSNovember 2018January 2022Abandon3720YesNo
16301337ADMINISTRATION MECHANISM FOR A MEDICAMENT DELIVERY DEVICENovember 2018April 2021Allow2920YesNo
16183123EXPANDABLE INTRODUCER ASSEMBLY AND METHOD OF USING SAMENovember 2018February 2021Allow2810NoNo
16098542DRIVE ASSEMBLY FOR A MEDICAMENT DELIVERY DEVICENovember 2018February 2023Allow5140YesNo
16162552MEDICAMENT DELIVERY DEVICE AND METHODS FOR DELIVERING DRUGS TO INFANTS AND CHILDRENOctober 2018July 2020Allow2120NoNo
16128323CHEMICAL FLUID INJECTION DEVICESeptember 2018May 2020Allow2020YesNo
16083779Unitary Medical Connector with a Rigid and a Resilient PortionSeptember 2018August 2022Allow4720YesNo
16083808Electrical Information Device for Communicating Information Related to a Medicament DeliverySeptember 2018October 2022Allow4930NoNo
16080652LIQUID MEDICATION INJECTION DEVICEAugust 2018May 2020Allow2120YesNo
16077974Safety Mechanism for a Medicament Delivery Device and a Medicament Delivery Device Comprising the SameAugust 2018November 2021Allow3920NoNo
16071203MEDICAMENT DELIVERY DEVICE AND METHODS FOR DELIVERING DRUGS TO INFANTS AND CHILDRENJuly 2018February 2020Allow1910YesNo
15993800DRUG CARTRIDGE WITH DRIVE SYSTEMMay 2018July 2020Allow2610YesNo
15992673BALLOON CATHETER DEVICE FOR IN VIVO POLYMERIZATION OF BIORESORBABLE SCAFFOLDSMay 2018June 2021Abandon3610NoNo
15777580MEDICAMENT DELIVERY DEVICEMay 2018May 2022Allow4830NoNo
15981721MEDICAMENT DEVICE FOR USE WITH A CONVENTIONAL SYRINGEMay 2018February 2021Allow3310NoNo
15955908TORQUEABLE STEERABLE SHEATHSApril 2018June 2022Allow5050YesNo
15956395Catheter System with Linear Actuation Control MechanismApril 2018February 2021Allow3410NoNo

Appeals Overview

This analysis examines appeal outcomes and the strategic value of filing appeals for examiner HUSSAIN, NIDAH MAHREEN.

Strategic Value of Filing an Appeal

Total Appeal Filings
2
Allowed After Appeal Filing
2
(100.0%)
Not Allowed After Appeal Filing
0
(0.0%)
Filing Benefit Percentile
99.7%
Higher than average

Understanding Appeal Filing Strategy

Filing a Notice of Appeal can sometimes lead to allowance even before the appeal is fully briefed or decided by the PTAB. This occurs when the examiner or their supervisor reconsiders the rejection during the mandatory appeal conference (MPEP § 1207.01) after the appeal is filed.

In this dataset, 100.0% of applications that filed an appeal were subsequently allowed. This appeal filing benefit rate is in the top 25% across the USPTO, indicating that filing appeals is particularly effective here. The act of filing often prompts favorable reconsideration during the mandatory appeal conference.

Strategic Recommendations

Filing a Notice of Appeal is strategically valuable. The act of filing often prompts favorable reconsideration during the mandatory appeal conference.

Examiner HUSSAIN, NIDAH MAHREEN - Prosecution Strategy Guide

Executive Summary

Examiner HUSSAIN, NIDAH MAHREEN works in Art Unit 3783 and has examined 190 patent applications in our dataset. With an allowance rate of 82.1%, this examiner has an above-average tendency to allow applications. Applications typically reach final disposition in approximately 33 months.

Allowance Patterns

Examiner HUSSAIN, NIDAH MAHREEN's allowance rate of 82.1% places them in the 56% percentile among all USPTO examiners. This examiner has an above-average tendency to allow applications.

Office Action Patterns

On average, applications examined by HUSSAIN, NIDAH MAHREEN receive 1.96 office actions before reaching final disposition. This places the examiner in the 45% percentile for office actions issued. This examiner issues fewer office actions than average, which may indicate efficient prosecution or a more lenient examination style.

Prosecution Timeline

The median time to disposition (half-life) for applications examined by HUSSAIN, NIDAH MAHREEN is 33 months. This places the examiner in the 49% percentile for prosecution speed. Prosecution timelines are slightly slower than average with this examiner.

Interview Effectiveness

Conducting an examiner interview provides a +22.9% benefit to allowance rate for applications examined by HUSSAIN, NIDAH MAHREEN. This interview benefit is in the 67% percentile among all examiners. Recommendation: Interviews provide an above-average benefit with this examiner and are worth considering.

Request for Continued Examination (RCE) Effectiveness

When applicants file an RCE with this examiner, 34.3% of applications are subsequently allowed. This success rate is in the 77% percentile among all examiners. Strategic Insight: RCEs are highly effective with this examiner compared to others. If you receive a final rejection, filing an RCE with substantive amendments or arguments has a strong likelihood of success.

After-Final Amendment Practice

This examiner enters after-final amendments leading to allowance in 48.7% of cases where such amendments are filed. This entry rate is in the 74% percentile among all examiners. Strategic Recommendation: This examiner shows above-average receptiveness to after-final amendments. If your amendments clearly overcome the rejections and do not raise new issues, consider filing after-final amendments before resorting to an RCE.

Pre-Appeal Conference Effectiveness

When applicants request a pre-appeal conference (PAC) with this examiner, 200.0% result in withdrawal of the rejection or reopening of prosecution. This success rate is in the 100% percentile among all examiners. Strategic Recommendation: Pre-appeal conferences are highly effective with this examiner compared to others. Before filing a full appeal brief, strongly consider requesting a PAC. The PAC provides an opportunity for the examiner and supervisory personnel to reconsider the rejection before the case proceeds to the PTAB.

Appeal Withdrawal and Reconsideration

This examiner withdraws rejections or reopens prosecution in 100.0% of appeals filed. This is in the 99% percentile among all examiners. Of these withdrawals, 100.0% occur early in the appeal process (after Notice of Appeal but before Appeal Brief). Strategic Insight: This examiner frequently reconsiders rejections during the appeal process compared to other examiners. Per MPEP § 1207.01, all appeals must go through a mandatory appeal conference. Filing a Notice of Appeal may prompt favorable reconsideration even before you file an Appeal Brief.

Petition Practice

When applicants file petitions regarding this examiner's actions, 34.5% are granted (fully or in part). This grant rate is in the 21% percentile among all examiners. Strategic Note: Petitions are rarely granted regarding this examiner's actions compared to other examiners. Ensure you have a strong procedural basis before filing a petition, as the Technology Center Director typically upholds this examiner's decisions.

Examiner Cooperation and Flexibility

Examiner's Amendments: This examiner makes examiner's amendments in 0.0% of allowed cases (in the 46% percentile). This examiner makes examiner's amendments less often than average. You may need to make most claim amendments yourself.

Quayle Actions: This examiner issues Ex Parte Quayle actions in 0.0% of allowed cases (in the 51% percentile). This examiner issues Quayle actions more often than average when claims are allowable but formal matters remain (MPEP § 714.14).

Prosecution Strategy Recommendations

Based on the statistical analysis of this examiner's prosecution patterns, here are tailored strategic recommendations:

  • RCEs are effective: This examiner has a high allowance rate after RCE compared to others. If you receive a final rejection and have substantive amendments or arguments, an RCE is likely to be successful.
  • Request pre-appeal conferences: PACs are highly effective with this examiner. Before filing a full appeal brief, request a PAC to potentially resolve issues without full PTAB review.
  • Appeal filing as negotiation tool: This examiner frequently reconsiders rejections during the appeal process. Filing a Notice of Appeal may prompt favorable reconsideration during the mandatory appeal conference.

Relevant MPEP Sections for Prosecution Strategy

  • MPEP § 713.10: Examiner interviews - available before Notice of Allowance or transfer to PTAB
  • MPEP § 714.12: After-final amendments - may be entered "under justifiable circumstances"
  • MPEP § 1002.02(c): Petitionable matters to Technology Center Director
  • MPEP § 1004: Actions requiring primary examiner signature (allowances, final rejections, examiner's answers)
  • MPEP § 1207.01: Appeal conferences - mandatory for all appeals
  • MPEP § 1214.07: Reopening prosecution after appeal

Important Disclaimer

Not Legal Advice: The information provided in this report is for informational purposes only and does not constitute legal advice. You should consult with a qualified patent attorney or agent for advice specific to your situation.

No Guarantees: We do not provide any guarantees as to the accuracy, completeness, or timeliness of the statistics presented above. Patent prosecution statistics are derived from publicly available USPTO data and are subject to data quality limitations, processing errors, and changes in USPTO practices over time.

Limitation of Liability: Under no circumstances will IronCrow AI be liable for any outcome, decision, or action resulting from your reliance on the statistics, analysis, or recommendations presented in this report. Past prosecution patterns do not guarantee future results.

Use at Your Own Risk: While we strive to provide accurate and useful prosecution statistics, you should independently verify any information that is material to your prosecution strategy and use your professional judgment in all patent prosecution matters.